Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067015 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT00067015: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00067015 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00067015, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy in different ways may cause less damage to normal tissue and may improve quality of life and help patients live more comfortably. Androgens can stimulate the growth of prostate cancer cells. Drugs such as goserelin and bicalutamide may fight cancer by stopping the production of androgens. It is not yet known whether radiation therapy is more effective with or without goserelin and bicalutamide in treating prostate cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of high-dose radiation therapy with or without bicalutamide and goserelin in treating patients who have prostate cancer.
Interventions
- PROCEDURE quality-of-life assessment
- RADIATION radiation therapy
- DRUG goserelin acetate
- DRUG bicalutamide
- PROCEDURE assessment of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2003-05 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
What the finished NCT00067015 record still lists
NCT00067015 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which quality-of-life assessment is the first listed.
NCT00067015 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00067015 about?
NCT00067015 is a clinical study titled "Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy in different ways may cause less damage to normal tissue and may improve quality of life and help patients live more comfortably. Androgens can stimulate the growth of prostate cancer cells. Drugs su...
What is the current status of trial NCT00067015?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2003-05. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00067015?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), radiation therapy (RADIATION), goserelin acetate (DRUG), bicalutamide (DRUG), assessment of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00067015?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00067015's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia